There's still time to register for tomorrow's webinar which is sponsored by PrimaryBid, featuring Zephyr Energy (ZPHR), SpectrumX, Scirocco Energy (SCIR) and Power Metal Resources (POW). Sign up here.

Less Ads, More Data, More Tools Register for FREE

Pernix to buy U.S. marketing rights to GSK, Pozen migraine drug

Wed, 14th May 2014 13:37

May 14 (Reuters) - Pernix Therapeutics Holdings Inc said it would buy the U.S. marketing rights for a migraine treatment developed by GlaxoSmithKline Plc and Pozen Inc for an upfront payment of $250 million.

Pernix's shares jumped as much as 42.5 percent in early trading on the Nasdaq.

The deal will nearly double Pernix's revenue by allowing it to expand its presence in the neurological market, the company said on Wednesday.

Pozen will get a warrant to purchase 500,000 Pernix shares, or about 1.3 percent of its outstanding stock, at Tuesday's closing price of $4.28.

The drug, Treximet, was approved by the U.S. Food and Drug Administration in April 2008 to treat acute migraine attacks in adults.

Pernix plans to the expand the use of the drug for children and expects to file for regulatory approval by the end of the year.

The company said the agreement is expected to close by Aug. 1 and that it will make royalty payments on net sales of the product. Glaxo was marketing the drug in the United States.

Mount Pleasant, South Carolina-based Pernix's shares were up 40 percent at $6.01. Pozen's shares were slightly lower at $8.68. (Reporting by Natalie Grover in Bangalore; Editing by Savio D'Souza)

Related Shares

More News

LONDON BROKER RATINGS: Downgrades for miners Anglo American and BHP

LONDON BROKER RATINGS: Downgrades for miners Anglo American and BHP

Today 09:44

Victrex hires ex-BP executive Vivienne Cox to replace Pentz as chair

Victrex hires ex-BP executive Vivienne Cox to replace Pentz as chair

Today 09:07

GlaxoSmithKline's Nucala given positive opinion by EU's CHMP

GlaxoSmithKline's Nucala given positive opinion by EU's CHMP

17 Sep 21 15:05

EXECUTIVE CHANGES: AIB adds two to board; Lamprell taps ex-Aramco exec

EXECUTIVE CHANGES: AIB adds two to board; Lamprell taps ex-Aramco exec

14 Sep 21 15:02

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.